Currently out of the existing stock ratings of Donald Ellis, 33 are a BUY (94.29%), 2 are a HOLD (5.71%).

Donald Ellis

Work Performance Price Targets & Ratings Chart

Analyst Donald Ellis, carries an average stock price target met ratio of 52.33% that have a potential upside of 51.38% achieved within 500 days. Previously, Donald Ellis worked at JMP.

Donald Ellis’s has documented 71 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on CLS, Celestica at 21-Dec-2021.

Wall Street Analyst Donald Ellis

Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 11/12/2019. The price target of $7 was fulfilled within 113 days with a profit of $4.43 (172.37%) receiving and performance score of 15.25.

Average potential price target upside

of $19.21 (75.02%) on CLSD (CLEARSIDE BIOMEDICAL).
of $17.37 (45.08%) on PCRX (PACIRA PHARMACEUTICALS).
of $10.37 (22%) on AERI (AERIE PHARMACEUTICALS).

ACRS Aclaris Therapeutics AERI Aerie Pharmaceuticals ENDP Endo International PLC HZNP Horizon Pharma PLC CLSD Clearside Biomedical OCUL Ocular Therapeutix PCRX Pacira Pharmaceuticals SLGL Sol Gel Technologies Ltd EOLS Evolus CLS Celestica MNLO Menlo Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Raghuram Selvaraju (HC WAINWRIGHT)